2023-05-01 17:01:55 ET
- Polydex Pharmaceuticals press release ( OTCPK:POLXF ): FY GAAP EPS of -$0.22.
- Revenue of $4.4M (+4.0% Y/Y).
For further details see:
Polydex Pharmaceuticals GAAP EPS of -$0.22, revenue of $4.4Mhome / stock / polxf / polxf news
2023-05-01 17:01:55 ET
For further details see:
Polydex Pharmaceuticals GAAP EPS of -$0.22, revenue of $4.4MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Polydex Pharms Ltd Company Name:
POLXF Stock Symbol:
Market:
IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2023-10-31 Deluxe Corporation (DLX) is expected to report $0.62 for Q4 2023 SkyWest Inc. (SKYW) is expected to report $0.11 for Q4 2023 1-800-FLOWERS.COM Inc. (FLWS) is expected to report $1.22 for Q2 2024 Brook...
Koss Corporation (KOSS) is expected to report for Q2 2024 Waterstone Financial Inc. (WSBF) is expected to report for Q4 2023 Silver Bull Resources Inc (SVBL) is expected to report for quarter end 2023-10-31 Xcel Energy Inc. (XEL) is expected to report $0.85 for Q4 2023 Sodexo ADR ...
Polydex Pharmaceuticals Inc (POLXF) is expected to report for quarter end 2023-10-31 RF Industries Ltd. (RFIL) is expected to report $-0.06 for Q4 2023 Northern Trust Corporation (NTRS) is expected to report $1.33 for Q4 2023 KeyCorp (KEY) is expected to report $0.22 for Q4 2023 S...